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Objective
To investigate tattoo-associated skin infections due to Mycobac-
terium chelonae using Emergency Department (ED) syndromic 
surveillance.
Introduction
In 2012, an outbreak of Mycobacterium chelonae infections in 
tattoo recipients in Rochester, NY was found to be associated with 
premixed tattoo ink contaminated before distribution.1 In May 2012, a 
case of M. chelonae was reported in a New York City (NYC) resident 
who received a tattoo with ink alleged to have been diluted with tap 
water. When a second case of M. chelonae in a tattoo recipient was 
reported in March 2013, an investigation was initiated. 
M. chelonae is not reportable in NYC other than in clusters re-
ported by providers or laboratories. To determine if there were addi-
tional tattoo-associated M. chelonae infections, we searched for cases 
using NYC ED syndromic surveillance.
Methods
ED syndromic data is de-identified and received daily from 49 
of the 52 acute care hospitals in NYC.2 Patient chief complaints are 
routinely scanned for key words and coded into syndromes (e.g. in-
fluenza-like illness, asthma). Chief complaint data containing the key 
word “tattoo” for the period January 1, 2008 – December 31, 2012 
were selected for analysis. The data were analyzed to describe trends 
and identify ED visits suspicious for skin infection (chief complaints 
containing the words “cellulitis,” “infected,” “redness,” etc.). 
ED visits that met our criteria in the five months preceding the 
recent M. chelonae report were selected for interview (November 
2012-March 2013). Names and contact information associated with 
the chief complaint data were obtained from hospital staff. A ques-
tionnaire including symptoms and duration, location of tattoo, name 
of tattoo parlor, and artist information was administered to evaluate 
possible M. chelonae cases requiring referral to a dermatologist for di-
agnosis. NYC laboratories were contacted to inquire about skin or soft 
tissue cultures from 2012 or 2013 in which M. chelonae was isolated.
Results
A total of 577 tattoo-related ED visits (TREDV) representing 43 
(88%) hospitals were identified during 2008-2012. A 26% increase 
in the proportion of TREDV per total ED visits among ages 18-64 
was noted from 2008-2012. Chi square for trend was not significant 
(p=0.11). Three-hundred eighty (66%) of these visits were identified 
with additional chief complaint wording suggestive of infection.
Thirty-one TREDV were identified in the five-month period pre-
ceding the second reported case of M. chelonae. ED visits were dis-
tributed among 19 NYC hospitals (range 1-4 visits/hospital). The 
median age of patients was 24 (range 16-48) and 65% (20) were 
women. For 18 (58%) patients, the chief complaint was coded as in-
fection, 10% (3) for rash, 10% (3) for swelling, 7% (2) for pain and 
16% (5) for other (allergic reaction, redness, warmth, not specified). 
Interviews were conducted for 14 (45%) of the TREDV. Rea-
sons for unsuccessful interviews included no reply to three phone 
call attempts and wrong or disconnected phone numbers. ED pa-
tients interviewed did not differ significantly from those who could 
not be reached on age, sex, or borough of residence. Thirteen (93%) 
interviewed patients had resolution of symptoms or a noninfectious 
diagnosis. One patient who had persistent symptoms was referred 
for additional medical care and was diagnosed with Staphylococcus 
aureus.
From January 2012 through March 2013, NYC laboratories re-
ported 13 isolates of M. chelonae from skin or soft tissue specimens, 
none of which were from patients with recent tattoos.
Conclusions
Using ED syndromic surveillance data, we determined that one 
case of tattoo-related M. chelonae was not part of an unrecognized 
outbreak or cluster of cases. In response to this concern about M. 
chelonae infections in tattoos, the Health Department sent a letter 
to all licensed tattoo artists in New York City advising them not to 
dilute tattoo inks with tap water. Syndromic surveillance is an option 
for finding cases when the event under surveillance is described by a 
unique and specific word or phrase, such as tattoo. This method can 
be similarly used for situations where diseases are either not report-
able or when cases may be otherwise difficult to capture.
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